Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

AXSMAXSM
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in AXSOME THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 967,172 shares of AXSM (AXSOME THERAPEUTICS INC), worth $236.8M as of 2026-Q2. The position was decreased (-16.8% shares). AXSM represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$236.8M

Current Shares

967,172

Total Value Change

+$155.1M

Total Shares Change

+58,713

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
967,172
-16.8%
$236.8M0.0%$244.77
0
2026-Q1
Increased
1.2M
+15.1%
$196.6M0.0%$164.05
35
2025-Q4
Increased
1M
+1.3%
$184.5M0.0%$148.79
31
2025-Q3
Increased
997,700
+0.8%
$121.2M0.0%$117.62
30
2025-Q2
Increased
989,453
+5.8%
$103.3M0.0%$103.36
32
2025-Q1
Increased
934,853
+2.5%
$109.1M0.0%$118.53
31
2024-Q4
Increased
912,538
+0.5%
$77.2M0.0%$84.78
30
2024-Q3
Increased
908,459
+2.7%
$81.7M0.0%$89.64
31

Other major holders of AXSM: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used